- Home
- FTFT vs ADVB Comparison
FTFT vs ADVB Comparison
Compare FTFT & ADVB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTFT
- ADVB
- Stock Information
- Founded
- FTFT N/A
- ADVB 2014
- Country
- FTFT United States
- ADVB United States
- Employees
- FTFT N/A
- ADVB N/A
- Industry
- FTFT Business Services
- ADVB Medical Specialities
- Sector
- FTFT Consumer Discretionary
- ADVB Health Care
- Exchange
- FTFT Nasdaq
- ADVB Nasdaq
- Market Cap
- FTFT 11.0M
- ADVB 9.1M
- IPO Year
- FTFT N/A
- ADVB 2025
- Fundamental
- Price
- FTFT $2.34
- ADVB $0.52
- Analyst Decision
- FTFT
- ADVB
- Analyst Count
- FTFT 0
- ADVB 0
- Target Price
- FTFT N/A
- ADVB N/A
- AVG Volume (30 Days)
- FTFT 372.2K
- ADVB 338.4K
- Earning Date
- FTFT 08-19-2025
- ADVB 11-03-2025
- Dividend Yield
- FTFT N/A
- ADVB N/A
- EPS Growth
- FTFT N/A
- ADVB N/A
- EPS
- FTFT N/A
- ADVB N/A
- Revenue
- FTFT $2,368,206.00
- ADVB N/A
- Revenue This Year
- FTFT N/A
- ADVB N/A
- Revenue Next Year
- FTFT N/A
- ADVB N/A
- P/E Ratio
- FTFT N/A
- ADVB N/A
- Revenue Growth
- FTFT N/A
- ADVB N/A
- 52 Week Low
- FTFT $1.01
- ADVB $0.34
- 52 Week High
- FTFT $5.70
- ADVB $4.10
- Technical
- Relative Strength Index (RSI)
- FTFT 51.27
- ADVB N/A
- Support Level
- FTFT $2.00
- ADVB N/A
- Resistance Level
- FTFT $3.88
- ADVB N/A
- Average True Range (ATR)
- FTFT 0.41
- ADVB 0.00
- MACD
- FTFT 0.06
- ADVB 0.00
- Stochastic Oscillator
- FTFT 18.95
- ADVB 0.00
About FTFT Future FinTech Group Inc.
Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.